Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Anthera Pharmaceuticals Inc (OTC : ANTH) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
Quote
| Last: | $0.001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.001 |
| Close: | $0.001 |
| High: | $0.001 |
| Low: | $0.001 |
| Volume: | 25,000 |
| Last Trade Date Time: | 06/04/2026 10:21:21 am |
Stock Data
| Market Cap: | $2,618 |
|---|---|
| Float: | 24,252,505 |
| Insiders Ownership: | 3.5% |
| Institutions: | 4 |
| Short Percent: | 2015026% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | http://www.anthera.com |
| Country: | US |
| City: | Hayward |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Anthera Pharmaceuticals Inc (OTC: ANTH).
